Literature DB >> 11146462

Primary role of the HLA class II DRB1*0301 allele in Graves disease.

M Zamani1, M Spaepen, M Bex, R Bouillon, J J Cassiman.   

Abstract

The association of the Graves disease (GD) with HLA DR3 and DQA1*0501 in Caucasians has been described previously. From these studies it could not be determined whether one specific locus was primarily involved. Using a case-control study design, we have examined the role of HLA class II gene polymorphisms in the predisposition for GD in a group of Belgian subjects. We demonstrated that both DRB1*0301 and DQA1*0501 alleles conferred significant susceptibility in the DRB1*0301-DQA1*0501 haplotype. The DRB1*0301 allele was the primary susceptibility allele for GD, however, because the susceptibility provided by DQA1*0501 was most likely due to it being in linkage disequilibrium with DRB1*0301. The DRB1*0701/x and DQA1*0201/x genotypes and the DRB1*0701-DQA1*0201 haplotype provided protection with an equal RR of 0.29. Predictive value calculations showed that testing for DRB1*0301 gave the highest positive predictive value for GD in females and males. This was, however, 10 times higher in females and predicted a 3.63% risk for a random female to develop GD. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11146462     DOI: 10.1002/1096-8628(20001218)95:5<432::aid-ajmg5>3.0.co;2-7

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  26 in total

1.  Genetics of thyroid function and disease.

Authors:  Vijay Panicker
Journal:  Clin Biochem Rev       Date:  2011-11

2.  Analysis of immune regulatory genes' copy number variants in Graves' disease.

Authors:  Amanda K Huber; Erlinda S Concepcion; Alisha Gandhi; Francesca Menconi; Eric P Smith; Mehdi Keddache; Yaron Tomer
Journal:  Thyroid       Date:  2010-11-08       Impact factor: 6.568

Review 3.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

4.  Genetics of autoimmune thyroid disease in the Lebanese population.

Authors:  C Farra; J Awwad; A Fadlallah; G Sebaly; G Hage; M Souaid; H Ashkar; R Medlej; M H Gannageh; G Halaby
Journal:  J Community Genet       Date:  2012-03-06

Review 5.  HLA Polymorphisms and Food Allergy Predisposition.

Authors:  Maria Kostara; Vasiliki Chondrou; Argyro Sgourou; Konstantinos Douros; Sophia Tsabouri
Journal:  J Pediatr Genet       Date:  2020-04-01

6.  Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes.

Authors:  Brian Golden; Lara Levin; Yoshiyuki Ban; Erlinda Concepcion; David A Greenberg; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2005-05-31       Impact factor: 5.958

7.  Frank Stinchfield Award: Identification of the At-risk Genotype for Development of Pseudotumors Around Metal-on-metal THAs.

Authors:  Brett K J Kilb; Andrew P Kurmis; Michael Parry; Karen Sherwood; Paul Keown; Bassam A Masri; Clive P Duncan; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

Review 8.  Selective IgA deficiency in autoimmune diseases.

Authors:  Ning Wang; Nan Shen; Timothy J Vyse; Vidya Anand; Iva Gunnarson; Gunnar Sturfelt; Solbritt Rantapää-Dahlqvist; Kerstin Elvin; Lennart Truedsson; Bengt A Andersson; Charlotte Dahle; Eva Ortqvist; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Mol Med       Date:  2011-08-04       Impact factor: 6.354

9.  Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families.

Authors:  Yaron Tomer; Yoshiyuki Ban; Erlinda Concepcion; Giuseppe Barbesino; Ronald Villanueva; David A Greenberg; Terry F Davies
Journal:  Am J Hum Genet       Date:  2003-09-12       Impact factor: 11.025

10.  Graves' disease associated with anticardiolipin antibody positivity and acquired protein S deficiency.

Authors:  Tomohiro Nakayama; Tatsuo Yamamoto; Katsuo Kanmatsuse; Shinichiro Kokubun
Journal:  Rheumatol Int       Date:  2003-02-26       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.